Navigation Links
Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
Date:11/10/2008

cumulative impact of cost saving initiatives implemented over the previous twelve months, lower accrued compensation costs, and a recovery of previously incurred legal expenses as a result of a mediation settlement.

Adjusted earnings per share on a non-GAAP basis, as explained below under the heading "Use of Non-GAAP Financial Measures," was $0.01 compared to $0.03 for third quarter of 2007, reflecting the decrease of an estimated $4.5 million of contribution margin related to the non-recurring contract and license revenues, which was partially offset by cost improvements.

"Caliper's strategic transformation to higher growth, higher profit product lines continues to progress. We have divested two product lines, sharpened our focus, consolidated operations, reduced costs, and strengthened our balance sheet," said Kevin Hrusovsky, President and CEO of Caliper Life Sciences. "These advances, coupled with reconfiguring our resources into three strategic business areas, should accelerate our crossover to profitability."

Key Highlights:

-- Non-core Product line Divestitures Strengthen Balance Sheet. Earlier today Caliper completed the sale of two non-core product lines in transactions netting approximately $18.8 million in cash proceeds and the assumption by the purchasers of such product lines of approximately $2.0 million of liabilities.

-- In a transaction both announced and completed today, Caliper sold its AutoTrace product line to Dionex Corporation for approximately $5.0 million. The AutoTrace instrument is designed for water sample clean-up by solid phase extraction prior to the analysis of the sample for contaminants, and is generally sold for automating water testing in the environmental market.

-- The previously announced PDQ product line sale to SOTAX Corporation was completed for $15.8 million, including cash proceeds of approximately $13.8 million. The parties also intend to enter into a long-term lease agreement, p
'/>"/>

SOURCE Caliper Life Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Caliper Enters Agreement to Divest Non-Core Pharmaceutical Development & Quality Analysis Product Line
2. Caliper Life Sciences Third Quarter 2008 Financial Results Conference Call Notice
3. Caliper Life Sciences and DiscoveRx Announce Availability of PathHunter eXpress Reagents for GPCR Assays
4. Caliper Life Sciences to Present at UBS Global Life Sciences Conference
5. Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
6. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
7. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
8. Caliper Life Sciences Reports Second Quarter 2008 Results
9. Caliper Life Sciences Second Quarter 2008 Financial Results Conference Call Notice
10. Caliper Life Sciences Added to Russell 3000(R) Index
11. Caliper Life Sciences to Present at Deutsche Banks 33rd Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Nashville Fertility Center announced that Dr. George ... Society for Reproductive Medicine (ASRM), a leading professional organization ... In his new role as treasurer, Dr. Hill ... will have a voice in furthering the mission of ... since 1984 when he joined while conducting fellowship training ...
(Date:12/24/2014)... December 23, 2014 PharmaBoardroom,s ... out today and available for free download , digs ... change and growth in the sector today. One ... successes has been in developing a homegrown pharmaceutical manufacturing base, ... production still remains some way off. A cursory comparison with ...
(Date:12/22/2014)... Md. , Dec. 22, 2014 /PRNewswire/ ... SYN), a developer of pathogen-specific therapies for ... on protecting the microbiome, today announced positive ... Phase 1a clinical trial of SYN-004, the ... prevention of Clostridium difficile (C. difficile) ...
(Date:12/22/2014)... 2014 The American Journal ... original research, reviews and editorials addressing developments and ... today published a provocative article exploring the role ... and potential treatment of prostate cancer. , ... proposes the possibility that there could be a ...
Breaking Biology Technology:Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4
... Capital Partners and Versant Ventures Lead ... Help Transform Clinical Microbiology, MADISON, Wis., Sept. 12 ... in equity financing. The round,was led by CHL Medical Partners, ... also participating. In,conjunction, CHL,s Ron Lennox will become chairman of ...
... raw materials for the chemical industry and generate power ... manufacturing processes. , Making synthesis gas - a blend ... step in turning natural gas or biomass into bulk ... and ammonia, which are the feedstock of the global ...
... in Clean Technology and Global Business Potential, ... Inc., a,leading algal biotechnology company, today announced that ... the GoingGreen 100 Top Private Companies for,2007. The ... the,AlwaysOn editorial panel. In order to be eligible ...
Cached Biology Technology:OpGen Announces $23.6 Million Series A Financing 2OpGen Announces $23.6 Million Series A Financing 3A POX on syn 2Solazyme, Inc. Selected by AlwaysOn as a GoingGreen 100 Top Private Company Award Winner 2Solazyme, Inc. Selected by AlwaysOn as a GoingGreen 100 Top Private Company Award Winner 3
(Date:12/17/2014)... 2014  HITLAB SM announced today its ... to confirm its adherence to current U.S. Food ... HITLAB to conduct regulated smart device and smart ... patient safety and research quality. "HITLAB ... and delivery with innovative technology," said Laura ...
(Date:12/17/2014)... 2014 Research and Markets ( ... "Global Chemical Sensor Market 2015-2019" report ... http://photos.prnewswire.com/prnh/20130307/600769 One major trend upcoming ... medical sensors in biomedical applications. Chemical sensors help ... correct diagnosis during surgical procedures. The Global Chemical ...
(Date:12/15/2014)... DUBLIN , Dec. 12, 2014 Research ... announced the addition of the "Global Facial ... http://photos.prnewswire.com/prnh/20130307/600769 ... the identification of individuals. Facial recognition system measures ... as nose, jaw edges, mouth, and the distance ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... /PRNewswire-iReach/ -- We,ve heard they may be easy enough ... yoga facial exercises regimen, the whole face and neck ... exercises using the fingertips are oftentimes performed to generate ... really work? (Photo: http://photos.prnewswire.com/prnh/20130710/CG44610 ) ...
... people with schizophrenia have marked problems with motivation, ... These negative symptoms of schizophrenia can be disabling ... For many years it was thought this was ... with successful goal attainment. However, recent laboratory studies ...
... Lithuania , July 10, 2013   ... identification technologies, today announced new releases across their ... including: MegaMatcher 4.5 multi-biometric SDK for large-scale applications, ... facial identification, VeriEye 2.7 for iris identification and ...
Cached Biology News:Getting Rid of Facial Wrinkles and Toning Up in 2013 2Getting Rid of Facial Wrinkles and Toning Up in 2013 3Calculating the value of effortful behavior: A clue to schizophrenia-related disability? 2Neurotechnology Announces MegaMatcher Accelerator 6.0 High-speed, High-volume Multibiometric Identification Solution and Updates to Entire Biometric Product Line 2Neurotechnology Announces MegaMatcher Accelerator 6.0 High-speed, High-volume Multibiometric Identification Solution and Updates to Entire Biometric Product Line 3Neurotechnology Announces MegaMatcher Accelerator 6.0 High-speed, High-volume Multibiometric Identification Solution and Updates to Entire Biometric Product Line 4
Anti-Protein Kinase-A (PKA) Regulatory subunit IIB; rabbit host...
Goat polyclonal to STMN2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: AKTAMAYKEK, corresponding to C terminal amino acids 2-11 of STMN2. Entrez Gene ID: 11075 Swi...
... polyclonal to PAX3 This protein is ... family of transcription factors. Members of the ... domain and a paired-type homeodomain. These proteins ... in paired box gene 3 are associated ...
Mouse monoclonal antibody to RNase L...
Biology Products: